Patent 7910600 was granted and assigned to Cylene Pharmaceuticals on March, 2011 by the United States Patent and Trademark Office.
The invention relates in part to molecules having certain biological activities that include, but are not limited to, inhibiting cell proliferation, and modulating protein kinase activity. Molecules of the invention can modulate casein kinase (CK) activity. The invention also relates in part to methods for using such molecules.